Literature DB >> 20665

Biogenic amine synthesis defect in dihydropteridine reductase deficiency.

S H Koslow, I J Butler.   

Abstract

In the enzymatic hydroxylation of aromatic amino acids, tetrahydrobiopterin is the essential cofactor. Regeneration of tetrahydrobiopterin requires dihydropteridine reductase, without which there should be a deficiency of hydroxylated amino acids and their products, biogenic amines. Assay of biopsied brain cortex of a patient with a deficiency of dihydropteridine reductases showed low concentrations of serotonin and dopamine, and this was reflected in the concentrations of their major metabolites measured in cerebrospinal fluid from lumbar, ventricular, and subarachnoid spaces. The metabolite concentrations were restored to normal, or above normal, by treatment with specific amino acids which bypass the metabolic block at the hydroxylation step. It is postulated that the seizures and neurological deterioration of the patient were related to a deficiency in the synthesis of biogenic amine neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20665     DOI: 10.1126/science.20665

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

Review 1.  Food intolerance in humans.

Authors:  R H Herman; L Hagler
Journal:  West J Med       Date:  1979-02

2.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

3.  MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.

Authors:  Masakazu Ishii; Shunichi Shimizu; Yuki Sakairi; Ayumu Nagamine; Yuika Naito; Yukiko Hosaka; Yuko Naito; Tatsuya Kurihara; Tomomi Onaya; Hideto Oyamada; Atsuko Imagawa; Kenji Shida; Johji Takahashi; Katsuji Oguchi; Yutaka Masuda; Hajime Hara; Shino Usami; Yuji Kiuchi
Journal:  Mol Cell Biochem       Date:  2011-12-23       Impact factor: 3.396

4.  Two new mutations in the dihydropteridine reductase gene in patients with tetrahydrobiopterin deficiency.

Authors:  I Dianzani; D W Howells; A Ponzone; J A Saleeba; P M Smooker; R G Cotton
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

5.  Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.

Authors:  R R McInnes; S Kaufman; J J Warsh; G R Van Loon; S Milstien; G Kapatos; S Soldin; P Walsh; D MacGregor; W B Hanley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Octopamine signaling in the metazoan pathogen Schistosoma mansoni: localization, small-molecule screening and opportunities for drug development.

Authors:  Nelly El-Sakkary; Steven Chen; Michelle R Arkin; Conor R Caffrey; Paula Ribeiro
Journal:  Dis Model Mech       Date:  2018-07-30       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.